Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £12.77 per share on 15 October 2009, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $39.62 per ADR on 15 October 2009, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 8 October 2009.
Ordinary shares | ADRs | |
Mr A P Witty | 229.07 | |
Mr J S Heslop | 0.01 | |
Dr M M Slaoui | 133.56 | |
Mrs C E Bruck Slaoui | 39.64 | |
Mr S M Bicknell | 71.17 | |
Mr J M Clarke | 139.34 | |
Mr M Dunoyer | 86.27 | |
Mr E J Gray | 152.25 | |
Mr D Learmouth | 41.34 | |
Mr W C Louv | 49.59 | |
Mr D J Phelan | 136.73 | |
Dr D Pulman | 79.09 | |
Mr D S Redfern | 66.05 | |
Ms C Thomas | 50.17 | |
Mr J R Stéphenne | 435.92 |
The Company was advised of this information on 19 October 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
20 October 2009
RNS news service provided by Hemscott Group Limited.